Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_assertion type Assertion NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_head.
- NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_assertion description "[A point mutation (V600E) in the BRAF oncogene is a prognostic biomarker and may predict for nonresponse to anti-EGFR antibody therapy in patients with colorectal carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_provenance.
- NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_assertion evidence source_evidence_literature NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_provenance.
- NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_assertion SIO_000772 23657789 NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_provenance.
- NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_assertion wasDerivedFrom befree-2016 NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_provenance.
- NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_assertion wasGeneratedBy ECO_0000203 NP1076186.RAiaOCQN-W-g62lvik9YfAmVAoY_8YqM5s1IUaxfFsMoE130_provenance.